Table of Content


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Microbiome Market, by Product
1.4.2 North America Human Microbiome Market, by Disease Type
1.4.3 North America Human Microbiome Market, by Technology
1.4.4 North America Human Microbiome Market, by Application
1.4.5 North America Human Microbiome Market, by Type
1.4.6 North America Human Microbiome Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Human Microbiome Market by Product
3.1 North America Drugs Market by Country
3.2 North America Diagnostic Tests Market by Country
3.3 North America Probiotics?Market by Country
3.4 North America Prebiotics?Market by Country
3.5 North America Others Market by Country
Chapter 4. North America Human Microbiome Market by Disease Type
4.1 North America Infectious Diseases Market by Country
4.2 North America Endocrine & Metabolic Disorders Market by Country
4.3 North America Gastrointestinal Diseases Market by Country
4.4 North America Cancer Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Human Microbiome Market by Technology
5.1 North America Genomics Market by Country
5.2 North America Proteomics Market by Country
5.3 North America Metabolomics Market by Country
Chapter 6. North America Human Microbiome Market by Application
6.1 North America Therapeutics Market by Country
6.2 North America Diagnostics Market by Country
Chapter 7. North America Human Microbiome Market by Type
7.1 North America Microbiome Consortia Transplantation (FMT) Market by Country
7.2 North America Peptide Market by Country
7.3 North America Live Biotherapeutic Product Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Human Microbiome Market by Country
8.1 US Human Microbiome Market
8.1.1 US Human Microbiome Market by Product
8.1.2 US Human Microbiome Market by Disease Type
8.1.3 US Human Microbiome Market by Technology
8.1.4 US Human Microbiome Market by Application
8.1.5 US Human Microbiome Market by Type
8.2 Canada Human Microbiome Market
8.2.1 Canada Human Microbiome Market by Product
8.2.2 Canada Human Microbiome Market by Disease Type
8.2.3 Canada Human Microbiome Market by Technology
8.2.4 Canada Human Microbiome Market by Application
8.2.5 Canada Human Microbiome Market by Type
8.3 Mexico Human Microbiome Market
8.3.1 Mexico Human Microbiome Market by Product
8.3.2 Mexico Human Microbiome Market by Disease Type
8.3.3 Mexico Human Microbiome Market by Technology
8.3.4 Mexico Human Microbiome Market by Application
8.3.5 Mexico Human Microbiome Market by Type
8.4 Rest of North America Human Microbiome Market
8.4.1 Rest of North America Human Microbiome Market by Product
8.4.2 Rest of North America Human Microbiome Market by Disease Type
8.4.3 Rest of North America Human Microbiome Market by Technology
8.4.4 Rest of North America Human Microbiome Market by Application
8.4.5 Rest of North America Human Microbiome Market by Type
Chapter 9. Company Profiles
9.1 Ferring Holdings SA
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research and Development Expense
9.1.5 Recent Strategies and Developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
9.2.1 Company Overview
9.2.2 Recent Strategies and Developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expense
9.3.4 Recent Strategies and Developments:
9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent Strategies and Developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
9.5.1 Company Overview
9.6 Synlogic, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense



List of Tables


TABLE 1 North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 2 North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 3 North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 4 North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 5 North America Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 6 North America Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 7 North America Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 8 North America Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 9 North America Probiotics?Market by Country, 2018 - 2021, USD Thousands
TABLE 10 North America Probiotics?Market by Country, 2022 - 2028, USD Thousands
TABLE 11 North America Prebiotics?Market by Country, 2018 - 2021, USD Thousands
TABLE 12 North America Prebiotics?Market by Country, 2022 - 2028, USD Thousands
TABLE 13 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 14 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 15 North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 16 North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 17 North America Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 18 North America Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 19 North America Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 20 North America Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 21 North America Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 22 North America Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 23 North America Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 24 North America Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 27 North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 28 North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 29 North America Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 30 North America Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 31 North America Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 32 North America Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 33 North America Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 34 North America Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 35 North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 36 North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 37 North America Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 38 North America Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 39 North America Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 40 North America Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 41 North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 42 North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 43 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 44 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 45 North America Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 46 North America Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 47 North America Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 48 North America Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 49 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 50 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 51 North America Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 52 North America Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 53 US Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 54 US Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 55 US Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 56 US Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 57 US Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 58 US Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 59 US Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 60 US Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 61 US Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 62 US Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 63 US Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 64 US Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 65 Canada Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 66 Canada Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 67 Canada Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 68 Canada Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 69 Canada Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 70 Canada Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 71 Canada Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 72 Canada Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 73 Canada Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 74 Canada Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 75 Canada Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 76 Canada Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 77 Mexico Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 78 Mexico Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 79 Mexico Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 80 Mexico Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 81 Mexico Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 82 Mexico Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 83 Mexico Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 84 Mexico Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 85 Mexico Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 86 Mexico Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 87 Mexico Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 88 Mexico Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 89 Rest of North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 90 Rest of North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 91 Rest of North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 92 Rest of North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 93 Rest of North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 94 Rest of North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 95 Rest of North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 96 Rest of North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 97 Rest of North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 98 Rest of North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 99 Rest of North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 100 Rest of North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 101 key information – Ferring Holdings SA
TABLE 102 Key information – Enterome
TABLE 103 KEY INFORMATION – Seres Therapeutics, Inc.
TABLE 104 Key Information – 4D pharma plc
TABLE 105 key Information – OptiBiotix Health Plc
TABLE 106 Key Information – Synlogic, Inc.
TABLE 107 Key Information – Second Genome, Inc.
TABLE 108 Key Information – Vedanta Biosciences, Inc.
TABLE 109 key information – Finch Therapeutics Group, Inc.
List of Figures
FIG 1 Methodology for the research